| Gene symbol | PDCD1 | Synonyms | CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q37.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | programmed cell death 1 | ||||
| GTO ID | GTC1691 |
| Trial ID | NCT03044743 |
| Disease | Gastric Carcinoma | Nasopharyngeal Carcinoma | T-Cell Lymphoma | Adult Hodgkin's Lymphoma | Diffuse Large B-Cell Lymphoma |
| Altered gene | PDCD1 |
| Therapeutic/Target gene | Target gene |
| Therapy | Gene editing |
| Treatment | PD-1 Knockout T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Phase I/II Trial of PD-1 Knockout EBV-CTLs for Advanced Stage EBV Associated Malignancies |
| Year | 2017 |
| Country | China |
| Company sponsor | Yang Yang |
| Other ID(s) | PD-1-KO-EBV-CTL |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||